Literature DB >> 3311007

Dietary fatty acids and myocardial function.

J M Lamers1, J M Hartog, P D Verdouw, W C Hülsmann.   

Abstract

It is widely recognized that dietary polyunsaturated fatty acids (PUFA's) and cholesterol can profoundly influence the development of atherosclerotic plaques in coronary vessels, which may lead to myocardial infarction. The possibility that dietary fatty acids may also directly influence cardiac function has received less attention. We therefore reviewed the evidence of the effects of dietary fatty acids, in particular n-3 and n-6 PUFA's, on myocardial phospholipid fatty acid composition and cardiovascular performance. Heart organelles appear to incorporate uncommon fatty acids like 22:1 and trans- 18:1. Diets enriched with 22:1 induce myocardial lipidosis. N-9, n-6 and n-3 families compete among membrane C20 and C22 acids. Several studies have dealt with the relation between diet-induced changes of cardiac membrane (sarcolemma, sarcoplasmic reticulum and mitochondria) phospholipids and membrane function. In view of the variety of diets used and of the membrane functions studied, the results do not permit equivocal interpretation. Several investigators have reported an altered stress response of the heart due to a change of PUFA's in the diet. In rats fed with a low 18:2n-6/18:3n-3 ratio combined with relatively low amounts of saturated fatty acids, a high incidence of myocardial lesions has been observed. Pigs are less sensitive but more susceptible to the development of vitamin E deficiency, when the dietary PUFA content is high. Increased contractility and coronary flow rate have been reported for Langendorff-perfused hearts of rats fed 18:2n-6-rich diets. The effects on coronary flow rate are possibly related to alterations in eicosanoid synthesis, which may also contribute to the reduction by n-6 or n-3 PUFA's in infarct size, magnitude of recovery of function and suppression of reperfusion arrhythmias following release of a coronary artery ligation. On the other hand, increased peroxidation of membrane lipids, due to their high content of n-3 PUFA, may be deleterious.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311007     DOI: 10.1007/978-3-662-08390-1_25

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  10 in total

1.  Dietary linolenic acid-mediated increase in vascular prostacyclin formation.

Authors:  H Rupp; M Turcani; T Ohkubo; B Maisch; C G Brilla
Journal:  Mol Cell Biochem       Date:  1996-09-06       Impact factor: 3.396

2.  Chronic hypoxia alters fatty acid composition of phospholipids in right and left ventricular myocardium.

Authors:  Jana Jezková; Olga Nováková; Frantisek Kolár; Eva Tvrzická; Jan Neckár; Frantisek Novák
Journal:  Mol Cell Biochem       Date:  2002-03       Impact factor: 3.396

3.  Influence of phospholipid long chain polyunsaturated fatty acid composition on neonatal rat cardiomyocyte function in physiological conditions and during glucose-free hypoxia-reoxygenation.

Authors:  I Durot; P Athias; F Oudot; A Grynberg
Journal:  Mol Cell Biochem       Date:  1997-10       Impact factor: 3.396

4.  Alterations in phospholipid N-methylation of cardiac subcellular membranes due to experimentally induced diabetes in rats.

Authors:  V Panagia; Y Taira; P K Ganguly; S Tung; N S Dhalla
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

5.  Exposure to the n-3 polyunsaturated fatty acid docosahexaenoic acid impairs alpha 1-adrenoceptor-mediated contractile responses and inositol phosphate formation in rat cardiomyocytes.

Authors:  C Reithmann; C Scheininger; T Bulgan; K Werdan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

Review 6.  Fish oil and the prevention and regression of atherosclerosis.

Authors:  L M Sassen; J M Lamers; P D Verdouw
Journal:  Cardiovasc Drugs Ther       Date:  1994-04       Impact factor: 3.727

7.  Myocardial protection by ischemic preconditioning: the influence of the composition of myocardial phospholipids.

Authors:  S al Makdessi; M Brändle; M Ehrt; H Sweidan; R Jacob
Journal:  Mol Cell Biochem       Date:  1995-04-12       Impact factor: 3.396

Review 8.  Occurrence and functions of the phosphatidylinositol cycle in the myocardium.

Authors:  J M Lamers; D H Dekkers; K Bezstarosti; J T Meij; H A van Heugten
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

Review 9.  Polyunsaturated fatty acids and signalling via phospholipase C-beta and A2 in myocardium.

Authors:  H W de Jonge; D H Dekkers; J M Lamers
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

10.  Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion.

Authors:  D E Thomas; Z Yousef; R A Anderson
Journal:  ISRN Cardiol       Date:  2011-07-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.